BioXcel Therapeutics (BTAIQ) Invested Capital (2017 - 2026)
BioXcel Therapeutics' Invested Capital was -$11.01 million in Q2 2026, compared with $1.02 million a year earlier.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Invested Capital (2017 - 2026) Analysis & Trends
For FY2025, Invested Capital at BioXcel Therapeutics came in at $14.13 million, up 50.2% from FY2024.
- Invested Capital shows a three-year compound annual growth rate of -56.3% (FY2022 to FY2025).
- In earlier years, Invested Capital was $9.41 million in FY2024 (-78.7%), $44.09 million in FY2023 (-74.0%) and $169.83 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Invested Capital in data going back to Q4 2017.
- Compared with a year earlier, Invested Capital was higher in two of the last six quarters, with an average decline of 38.8%.
- The best year-over-year quarter for Invested Capital over five years was Q4 2025 (growth of 50.2%); the worst was Q2 2025 (a decline of 96.5%).
- Per Business Quant data, BTAIQ's Invested Capital in the three quarters before Q2 2026 was -$5.25 million (Q1 2026), $14.13 million (Q4 2025) and $20.21 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 148.69 Bn |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | -11.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.01 Mn |
| Mar 31, 2026 | -5.25 Mn |
| Dec 31, 2025 | 14.13 Mn |
| Sep 30, 2025 | 20.21 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 15.35 Mn |
| Dec 31, 2024 | 9.41 Mn |
| Sep 30, 2024 | 18.81 Mn |
| Jun 30, 2024 | 28.71 Mn |
| Mar 31, 2024 | 29.27 Mn |
| Dec 31, 2023 | 44.09 Mn |
| Sep 30, 2023 | 58.49 Mn |
| Jun 30, 2023 | 102.71 Mn |
| Mar 31, 2023 | 148.07 Mn |
| Dec 31, 2022 | 169.83 Mn |
| Sep 30, 2022 | 218.68 Mn |
| Jun 30, 2022 | 225.34 Mn |
| Dec 31, 2017 | -611,000.00 |
API Access
BioXcel Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();